Approval for the next generation hta system with a redesigned operational unit (control unit, power cord, pedestal, iv pole) and a modified sterile procedure set.  The device, as modified, will be marketed under the trade name genesys hta system and is indicated for ablation of the endometrial lining of the uterus in premenopausal women with menorrhagia (excessive uterine bleeding) due to benign causes for whom childbearing is complete.